Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 3, 2005
Human Molecular Genetics 2005 14(8):1009-1017; doi:10.1093/hmg/ddi093
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/8/1009    most recent
ddi093v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mototani, H.
Right arrow Articles by Ikegawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mototani, H.
Right arrow Articles by Ikegawa, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese

Hideyuki Mototani1,3, Akihiko Mabuchi1, Susumu Saito4,{dagger}, Mikihiro Fujioka5, Aritoshi Iida2, Yoshio Takatori6, Akihiro Kotani7, Toshikazu Kubo5, Kozo Nakamura6, Akihiro Sekine8, Yoshinori Murakami10, Tatsuhiko Tsunoda9, Kohei Notoya3, Yusuke Nakamura2,8 and Shiro Ikegawa1,*

1Laboratory for Bone and Joint Diseases and 2Laboratory for SNP Analysis, Research Groups of Personalized Medicine, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan, 3Pharmaceutical Research Laboratories I, Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd, Osaka 532-8686, Japan, 4Department of Orthopaedic Surgery, Sumitomo Hospital, Nakanoshima 5-3-20, Kita-ku, Osaka 530-0005, Japan, 5Department of Orthopaedic Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan, 6Department of Orthopaedic Surgery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan, 7Department of Orthopaedic Surgery, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan, 8Laboratory for Genotyping and 9Laboratory for Medical Informatics, SNP Research Center, RIKEN, 1-7-22 Suehirocho, Tsurumi-ku, Yokohama 230-0045, Japan and 10Tumor Suppression and the Functional Genomics Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

* To whom correspondence should be addressed. Tel: +81 354495393; Fax: +81 354495393; Email: sikegawa{at}ims.u-tokyo.ac.jp

Received December 27, 2004; Revised February 14, 2005; Accepted February 22, 2005

Osteoarthritis (OA), a common skeletal disease, is a leading cause of disability among the elderly populations. OA is characterized by gradual loss of articular cartilage, but the etiology and pathogenesis of OA are largely unknown. Epidemiological and genetic studies have demonstrated that genetic factors play an important role in OA. To identify susceptibility genes for OA, we performed a large-scale, case–control association study using gene-based single nucleotide polymorphisms (SNPs). In two independent case–control populations, we found significant association (P=9.8x10–7) between hip OA and a SNP (IVS3–293C>T) located in intron 3 of the calmodulin (CaM) 1 gene (CALM1). CALM1 was expressed in cultured chondrocytes and articular cartilage, and its expression was increased in OA. Subsequent linkage-disequilibrium mapping identified five SNPs showing significant association equivalent to IVS3–293C>T. One of these (–16C>T) is located in the core promoter region of CALM1. Functional analyses indicate that the susceptibility –16T allele decreases CALM1 transcription in vitro and in vivo. Inhibition of CaM in chondrogenic cells reduced the expression of the major cartilage matrix genes Col2a1 and Agc1. These results suggest that the transcriptional level of CALM1 is associated with susceptibility for hip OA through modulation of chondrogenic activity. Our findings reveal the CALM1-mediated signaling pathway in chondrocytes as a novel potential target for treatment of OA.


{dagger} Present address: Department of Orthopaedic Surgery, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai, Osaka 591-8025, Japan


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S.-C. Mu, H.-C. Liu, J.-Y. Wu, M.-T. M. Lee, H.-P. Chuang, L.-K. Chen, and Y.-T. Chen
A large kindred of early-onset osteoarthritis of the knee and hip: excluding the link to COL2A1 gene
Rheumatology, April 1, 2009; 48(4): 371 - 374.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Mototani, A. Iida, M. Nakajima, T. Furuichi, Y. Miyamoto, T. Tsunoda, A. Sudo, A. Kotani, A. Uchida, K. Ozaki, et al.
A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese
Hum. Mol. Genet., June 15, 2008; 17(12): 1790 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
I. Meulenbelt, J. L. Min, S. Bos, N. Riyazi, J. J. Houwing-Duistermaat, H.-J. van der Wijk, H. M. Kroon, M. Nakajima, S. Ikegawa, A. G. Uitterlinden, et al.
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis
Hum. Mol. Genet., June 15, 2008; 17(12): 1867 - 1875.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Chapman, A. Takahashi, I. Meulenbelt, C. Watson, J. Rodriguez-Lopez, R. Egli, A. Tsezou, K. N. Malizos, M. Kloppenburg, D. Shi, et al.
A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility
Hum. Mol. Genet., May 15, 2008; 17(10): 1497 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J J Ryder, K Garrison, F Song, L Hooper, J Skinner, Y Loke, J Loughlin, J P T Higgins, and A J MacGregor
Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review
Ann Rheum Dis, May 1, 2008; 67(5): 584 - 591.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Masuya, K. Nishida, T. Furuichi, H. Toki, G. Nishimura, H. Kawabata, H. Yokoyama, A. Yoshida, S. Tominaga, J. Nagano, et al.
A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice
Hum. Mol. Genet., October 1, 2007; 16(19): 2366 - 2375.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Southam, J. Rodriguez-Lopez, J. M. Wilkins, M. Pombo-Suarez, S. Snelling, J. J. Gomez-Reino, K. Chapman, A. Gonzalez, and J. Loughlin
An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage
Hum. Mol. Genet., September 15, 2007; 16(18): 2226 - 2232.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Hata, K. Matsuda, T. Ninomiya, K. Yonemoto, T. Matsushita, Y. Ohnishi, S. Saito, T. Kitazono, S. Ibayashi, M. Iida, et al.
Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction
Hum. Mol. Genet., March 15, 2007; 16(6): 630 - 639.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. E. Ali-Khan and B. F. Hales
Novel Retinoid Targets in the Mouse Limb during Organogenesis
Toxicol. Sci., November 1, 2006; 94(1): 139 - 152.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Loughlin
Osteoarthritis linkage scan: more loci for the geneticists to investigate.
Ann Rheum Dis, October 1, 2006; 65(10): 1265 - 1266.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Yamazaki, D. McGovern, J. Ragoussis, M. Paolucci, H. Butler, D. Jewell, L. Cardon, M. Takazoe, T. Tanaka, T. Ichimori, et al.
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
Hum. Mol. Genet., November 15, 2005; 14(22): 3499 - 3506.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.